Modulation of lymphangiogenesis: A new target for aspirin and other nonsteroidal anti-inflammatory agents? A systematic review

Journal of Clinical Pharmacology

Volumn 52, Issue 11, 2012, Pages 1749-1754

  Yiannakopoulou, Eugenia ^a  

^a UNIVERSITY OF WEST ATTICA   (Greece)

Author keywords

cyclo oxygenase; Lymphangiogenesis; nonsteroidal anti inflammatory agents; tumor metastasis; VEGF C

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2; DEXAMETHASONE; DICLOFENAC; ETODOLAC; FLAVONOID; HYALURONIC ACID; KETOPROFEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SALICYLATE SODIUM; SALICYLIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN C;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER RISK; CARCINOMATOUS PERITONITIS; COLORECTAL CARCINOMA; DRUG EFFECT; DRUG TARGETING; ENZYME INHIBITION; ESOPHAGUS CANCER; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHEDEMA; METASTASIS; METASTASIS INHIBITION; NONHUMAN; PERITONEAL DIALYSIS; PROGNOSIS; REVIEW; RISK REDUCTION; SURGICAL WOUND; SYSTEMATIC REVIEW; TISSUE REGENERATION; TUMOR GROWTH;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; LYMPHANGIOGENESIS;

EID: 84868015396     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270011431066     Document Type: Review

References (34)

1. Weryńska B, Dziegiel P, Jankowska R. Role of lymphangiogenesis in lung cancer. Folia Histochem Cytobiol. 2009 ; 47: 333-342
2. Di JM, Zhou J, Zhou XL, et al. Cyclo-oxygenase II expression is associated with vascular endothelial growth factor C and lymph node metastasis in human prostate cancer. Arch Med Red. 2009 ; 40: 268-275
3. Timoshenko AV, Chakraborty C, Wagner GF, Lala PK. COX-2 mediated expression of the lymphangiogenic factor VEGF C in human cancer. Br J Cancer. 2006 ; 94: 1154-1163
4. Liu H, Yang Y, Xiao J, et al. Inhibition of cyclo-oxygenase II suppresses lymph node metastasis via VEGF-C. Anat Rec (Hoboken). 2009 ; 10: 1577-1583
5. Guo GL, Yang GL, Li ZY, et al. The effect of cyclo-oxygenase II on lymphangiogenesis in breast cancer. Zhonghua Wai Ke Za Zhi. 2008 ; 15: 132-135
6. Paydas S, Ergin M, Seydaoglu G, Erdogan S, Yavuz S. Prognostic significance of angiogenic, lymphangiogenic, antiapoptotic, inflammatory and viral factors in 88 cases with diffuse B large cell lymphoma and review of the literature. Leuk Res. 2009 ; 33: 1627-1635
7. Kubo H, Hosono K, Suzuki T, et al. Host prostaglandin EP3 receptor signalling relevant to tumor-associated lymphangiogenesis. Biomed Pharmacother. 2010 ; 64: 101-106
8. Iwata C, Kano MR, Komuro A, et al. Inhibition of cyclo-oxygenase II suppresses lymph node metastasis via inhibition of lymphangiogenesis. Cancer Res. 2007 ; 67: 10181-10189 (Pubitemid 350070790)
9. Barnes NL, Warnberg F, Farnie G, et al. Cyclo-oxygenase 2 inhibition: effect on tumor growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. Br J Cancer. 2007 ; 26: 575-582
10. Brasky TM, Bonner MR, Moysich KB, et al. Non steroidal anti-inflammatory drug use (NSAID) and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study Cancer Causes Control.. 2010 ; 9: 1503-1512
11. Shinaka R, Shibata MA, Morimoto J, Tanigawa N, Otsuki Y. COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis in a murine mammary cancer. Anticancer Res. 2006 ; 26: 4245-4254 (Pubitemid 46031497)
12. Zhang J, Ji J, Yuan F, et al. Cyclo-oxygenase 2 expression is associated with VEGF-C and lymph node metastasis in gastric cancer patients. Biomed Pharmacother. 2005 ; 59: S285 - S288
13. Zhang J, Ji J, Yuan F, et al. COX-2 expression in gastric cancer and its correlation with lymphangiogenesis and lymph node metastasis. Zhonghua Wai Ke Za Zhi. 2005 ; 8: 348-351
14. Hosono K, Suzuki T, Tamaki H, et al. Roles of prostaglandin EP3/EP4 receptor signalling in the enhancement of lymphangiogenesis during fibroblast-growth-2 induced granulation formation. Arterioscler Thromb Vasc Biol. 2011 ; 31 (5). 1049-1058
15. Liu H, Yang Y, Xiao J, et al. COX-2 mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer. Anat Rec (Hoboken). 2010 ; 293: 1838-1846
16. von Rahden BH, Stein HJ, Pühringer F, et al. Co-expression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. Cancer Res. 2005 ; 65: 5038-5044 (Pubitemid 40827311)
17. Fabbrini P, Schilte MN, Zareie M, et al. Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis. Nephrol Dial Transplant. 2009 ; 24: 3669-3676
18. Greco KV, Lara PF, Oliveira-Filho RM, Greco RV, Sudo-Hayashi LS. Lymphatic regeneration across an incisional wound: inhibition by dexamethasone and aspirin, and acceleration by a micronized purified flavonoid fraction. Eur J Pharmacol. 2006 ; 551: 131-142 (Pubitemid 44648056)
19. Nakamura K, Radhakrishnan K, Wong YM, Rockson SG. Anti inflammatory pharmacotherapy with ketoprofen ameliorates experimental vascular insufficiency in mice. PLoS One. 2009 ; 4: e8380
20. Gou HF, Chen XC, Zhu J, et al. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications. J Exp Clin Cancer Res. 2011 ; 30: 14
21. Da MX, Wu XT, Wang J, et al. Expression of cyclo-oxygenase 2 and vascular endothelial growth factor C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer. Arch Med Res. 2008 ; 39: 92-99 (Pubitemid 350192014)
22. Zhou BT, Yang W, Xu XH, et al. Correlation of cyclo-oxygenase II expression with microlymphatic density and its clinical significance. Zhonghua Wai Ke Za Zhi. 2010 ; 13: 699-702
23. Bhattacharjee RN, Timoshenko AV, Cai J, Lala PK. Relationship between cyclo-oxygenase-II and human epidermal growth factor receptor 2 in vascular epidermal growth factor C up regulation and lymphangiogenesis in human breast cancer. Cancer Sci. 2010 ; 101: 2026-2032
24. Zhang XH, Huang DP, Guo GL, et al. Co-expression of VEGF-C and COXII and its association with lympahngiogenesis in human breast cancer. BMC Cancer. 2008 ; 8: 4
25. Guo X, Chen Y, Xu Z, Xu Z, Qian Y, Yu X. Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density and clinicopathologic characteristics in human non small cell lung cancer. Acta Biochim Biophys Sin. 2009 ; 4: 217-222
26. Zhang- HZ, Hua P, Li HG, et al. Expression of vascular endothelial growth factor C and cyclooxygenase 2 in non small cell lung carcinoma and their clinical significance. Zhonghua Wai Ke Za Zhi. 2005 ; 27: 734-737
27. Su JL, Shih JY, Yen ML, et al. Cyclo-oxygenase II induces EP-1 and HER-2 new dependent vascular endothelial growth factor C upregulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res. 2004 ; 64: 554-564
28. Soumaoro LT, Uetake H, Takagi Y, et al. Coexpression of VEGF-C and COX-2 in human colorectal cancer and its association with lymph node metastasis. Dis Colon Rectum. 2006 ; 3: 392-398
29. Longatto-Filho A, Pinheiro C, Pereira SM, et al. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix. Gynecol Oncol. 2007 ; 107: 45-51 (Pubitemid 47495944)
30. Kyzas PA, Stefanou D, Agnantis NJ. COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamus cell carcinoma. Mod Pathol. 2005 ; 18: 153-160 (Pubitemid 40128108)
31. Flister MJ, Wilber A, Hall KL, et al. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappa B and Prox1. Blood. 2010 ; 115 (2). 418-429
32. Jana NR. NSAIDs and apoptosis. Cell Mol Life Sci. 2008 ; 65: 1295-1301
33. Yiannakopoulou ECh, Tyligada E. Protective effect of salicylates against hydrogen peroxide stress in yeast. J Appl Microbiol. 2009 ; 4: 843-845
34. Cohen B, Addadi Y, Sapoznik S, et al. Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium -derived growth factor/76. Neoplasia. 2009 ; 11: 921-933